<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>27</ref-type><contributors></contributors><titles><title><style face="normal" font="default" size="100%">Thematic Working Group 5: Personalized Medicine</style></title></titles><keywords><keyword><style  face="normal" font="default" size="100%">(hemato)oncology</style></keyword><keyword><style  face="normal" font="default" size="100%">cancer</style></keyword><keyword><style  face="normal" font="default" size="100%">Next-generation sequencing (NGS)</style></keyword><keyword><style  face="normal" font="default" size="100%">personalized medicine</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2014</style></year></dates><publisher><style face="normal" font="default" size="100%">Sciensano</style></publisher><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p&gt;This document summarizes the outcome of the discussions within the thematic working group during the period June 2013 - Octobre 2014. There was decided on&amp;nbsp;a common basis of understanding of what 'personalized medicine' means and came to a working definition for this group. A litterature study was performed and relevant information was compiled into a review paper.&lt;/p&gt;
</style></abstract></record></records></xml>